Increase in the incidence of lung-related syndromes and rise in geriatric population, in the last few years has driven the growth of the lung injury market in more than one way.
Increase in the incidence of lung-related syndromes and rise in geriatric population, in the last few years has driven the growth of the lung injury market in more than one way. At the same time, rise in awareness about the treatment of ARDA and ALI has supplemented the market growth yet more. Moreover, the fact that pipeline drugs for the treatment of acute lung injury are extensively being studied for a lot clinical trials has been highly beneficial for the market growth. At the same time, huge expansion of the lung injury research sphere has augmented the demand for top-end therapies.
As per Centre for Disease Control and Prevention, COPD along with acute lung injury are the third prominent cause of death in the United States. Moreover, incorporation of novel technologies and obtainability of an array of potential drugs for the treatment of lung injury have kindled the market growth.
According to Allied Market Research, the global lung injury market is anticipated to manifest a considerable CAGR from 2021 to 2030. Rising wakefulness associated with daily health diagnostics has now made patients prefer digital diagnostic solutions more over hospital or laboratory visit, and this avant-garde technology platform is expected to heighten the approachability for both the patients as well as the doctors.
The key market players in the industry have also started implementing several new strategies to cope up with the highly competitive layout.
Researchers in Sweden have recently come up with top-class X-ray imaging solutions that can produce high resolution, 3D imageries of the lungs of free-breathing mice, even without utilizing mechanical ventilation. The method evolved at KTH Royal Institute of Technology can now support research activities on lung diseases to be accomplished without risking injury to mice by means of artificial respiration.
Download Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/13445
Top Leading Players:
- Apeptico Forschung Und Entwicklung GmBH
- Bayer AG
- General Electric Company
- Glaxosmithkline Plc,
- Koninklijke Philips N.V.
- Linde Plc.
- Medtronic Plc.
- Ony Biotech Inc
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Impact of Covid-19 on Lung Injury Market-
Here, it’s worth mentioning that individuals infected with the corona virus tend to suffer from severe respiratory failure syndromes. Roughly thirty percent of the patients happen to develop deadly acute respiratory distress pattern giving way to high mortality rate. At the same time, comorbid and geriatric patients are also more susceptible to life-threatening respiratory syndromes. These factors have, quite naturally, increased the demand for exclusive therapies to treat the medical conditions, thereby impacting the global lung injury market positively.